NEWSROOM
News & Stories
Newsroom
Press Releases
MammaPrintยฎ Approved for Reimbursement in Germany
IRVINE, Calif.,ย Oct. 21, 2020ย /PRNewswire/ --ย Agendia Inc., a world leader in precision oncology for breast cancer, announced today that the Federal Joint Committee (G-BA) has approved MammaPrintยฎ , Agendia's 70-Gene Breast Cancer Recurrence Assay. The G-BA Read More
Agendia to Participate in Stifel 2020 Virtual Healthcare Conference
Irvine, Calif., October 15, 2020 โ Agendia, Inc., a world leader in precision oncology for breast cancer, today announced its participation in the 2020 Stifel Virtual Healthcare Conference, which takes place November 16-18, 2020. Agendia Read More
Agendia, HiSS Diagnostics and PathoNext offer local MammaPrint and BluePrint testing for breast cancer patients in Germany
IRVINE, CALIF., U.S โ 6 October 2020 โ Agendia Inc., a world leader in precision oncology for breast cancer, announced today the availability of local testing for its CE-marked MammaPrintยฎ BluePrintยฎ Breast Cancer Recurrence and Read More